Giovanni Caforio
Appearance
| Giovanni Caforio | |
| Born | born 1964 |
|---|---|
| Nationality | Italian, American |
| Occupation | Pharmaceutical executive |
| Title | Chairman of the Board, Novartis |
| Known for | Former Chairman and CEO of Bristol-Myers Squibb |
| Education | Doctor of Medicine (M.D.) |
Chief Executive Officer Bristol-Myers Squibb [1] [2] [3] [4] [4][4] [2]"An exit interview with Bristol Myers Squibb CEO Giovanni Caforio". STAT. October 30, 2023. Retrieved 2026-02-24. [1] Christopher Boerner,[5]"In his swan song at Bristol Myers Squibb, former CEO Giovanni Caforio pulled down $19.7M". Fierce Pharma. March 21, 2024. Retrieved 2026-02-24. [6] [7]]] Thomas Schinecker Raul Ruiz Vas Narasimhan Ted Sarandos Jeff Miller
- ↑ 1.0 1.1 "Bristol Myers Squibb Announces Leadership Transition Plan". Bristol Myers Squibb. April 26, 2023. Retrieved 2026-02-24.
- ↑ 2.0 2.1 "Novartis nominates former Bristol Myers CEO Giovanni Caforio as its new chair. Will M&A deals follow?". Fierce Pharma. April 23, 2024. Retrieved 2026-02-24.
- ↑ "Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting". Novartis. March 7, 2025. Retrieved 2026-02-24.
- ↑ 4.0 4.1 4.2 "Giovanni Caforio, M.D.". Novartis. March 7, 2025. Retrieved 2026-02-24.
- ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedstat-exit - ↑ "Former Bristol Myers CEO tapped as Novartis' next board chair". BioPharma Dive. April 23, 2024. Retrieved 2026-02-24.
- ↑ "As former BMS CEO Giovanni Caforio plots move to Novartis, will noncompete issues come into play?". Fierce Pharma. July 1, 2024. Retrieved 2026-02-24.